Beyond the Therapy – Is a Phase III oncology trial failure always a drug failure? ❓🎯
Is a Phase III oncology trial failure always a drug failure ❓ A recent article published on Applied Clinical Trials highlights an important reality of modern oncology research: in many cases, late-stage trial setbacks may reflect the complexity of cancer biology rather than the failure of the therapeutic target itself. 🎯 As precision oncology continues […]